Status:

RECRUITING

18F-choline Positron-emission-tomography - Computed-tomography Compared to Conventional Imaging for Localizing Diseased Parathyroid Glands in Primary Hyperparathyroidism

Lead Sponsor:

Region Skane

Conditions:

Primary Hyperparathyroidism

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The goal of this open, single-center, prospective, randomized, clinical study is to compare imaging with \[18F\]fluoromethyl-dimethyl-2-hydroxyethylammonium (18F-choline) positron-emission-tomography ...

Detailed Description

1 Improving precision in parathyroid surgery 18F-choline-PET-CT vs ultrasonography and 99-technetium sestamibi scintigraphy in preoperative localization for pHPT - A randomized trial Martin Almquist, ...

Eligibility Criteria

Inclusion

  • Proven primary hyperparathyroidism Indication for surgery Adult (\>18 years)

Exclusion

  • Inability to give informed consent Allergy to contrast Pregnancy and breastfeeding

Key Trial Info

Start Date :

January 1 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

February 28 2027

Estimated Enrollment :

88 Patients enrolled

Trial Details

Trial ID

NCT07138820

Start Date

January 1 2023

End Date

February 28 2027

Last Update

August 24 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Skåne University Hospital

Lund, Sweden